03:50

Relapsed Myeloma Treatment: Modify or Start Anew? | #myeloma

05:08

What is Relapsed and Refractory Myeloma? | Experts Explain #myeloma

13:36

Recommended Prophylactic Medications #myeloma

03:17

What is Gamma Secretase? #myeloma

05:19

Second chances with BCMA second line therapy | #myeloma

06:11

Choosing the right BCMA directed therapy for you #myeloma

04:13

Approved Myeloma BCMA Therapies #myeloma

08:39

What types of BCMA directed therapies are being explored in myeloma? #myeloma

03:36

What is BCMA? #myeloma

02:14

What is BCMA Directed therapy? #myeloma

27:16

All about ELREXFIO (elranatamab)

28:40

All About TALVEY (talquetamab)

07:58

What is the future of clinical trials?

01:13

What are patient reported outcomes?

04:03

How are bispecific antibodies be used in combination with other anti Myeloma therapies?

04:59

MRD tests and surrogate endpoint testing

09:38

Is it possible to predict who are the patients who might have that delayed neurotoxicity?

07:34

Surrogate endpoints | What do they mean?

14:24

How do you choose which Car T cell product to use?

04:13

Primary and secondary endpoints in a clinical trial | What are they?

04:37

What are Trispecific antibodies?

01:15

What is a Hazard Ratio?

04:20

What is meant by an out of spec CAR T product?

03:23

Basket and umbrella trials | What's the difference?

03:06

What testing is done prior to CAR-T cell therapy?

01:21

Informed consent forms | What are they?

11:58

What should patients know about bispecific antibody therapy and the risk for infection?

02:21

What is translational research?

07:17

Is CAR T a one time treatment?

01:11

What are clinical trial control and experimental arms?

06:08

What do you see as the future of MRD?

00:39

Accelerating to a CURE | HealthTree 2.0 Launch Trailer

01:55

Blind and double blind clinical trials

04:17

Is the dosing for bispecific antibodies ongoing until progression or for a set period of time?

01:25

Randomized clinical trials

01:33

What is Antibody Interference?

08:16

Phases of Clinical Trials: Explained

07:01

Is MRD testing a Standard of Care?

01:57

Can patients drop out of a trial if they want to?

08:45

How can MRD negativity be used as an endpoint in clinical trials?

01:57

What does it cost to be part of a clinical trial?

09:59

Can knowing your MRD status help guide treatment?

03:37

Are there placebos in myeloma clinical trials?

01:20

How can someone be MRD negative and not in a Complete Response?

01:53

What are eligibility criteria for a clinical trial?

04:54

Does everyone need to become MRD negative to have good outcomes?

03:03

Where to find clinical trials

10:52

What are some possible uses of MRD testing?

02:23

When should a patient consider a clinical trial?

02:00

What is sustained MRD negativity?

02:57

Why are clinical trials important?

04:41

If you have measurable disease is there a reason to consider MRD testing?

01:23

What are clinical trials in myeloma?

05:19

Who should get MRD testing?

14:02

REGN5459 | Therapies on the Horizon

05:44

Can MRD testing be done on a blood sample?

08:53

How is MRD testing done?

03:11

What does sensitivity of MRD testing mean?

03:55

What is MODAKAFUSP ALFA (TAK 573)?

05:28

What is the role of imaging in MRD testing?